The Department of Obstetrics and Gynecology, The Genetics and Prenatal Diagnosis Center, The First Affiliated Hospital of Zhengzhou University, Henan, China.
The Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Henan, China.
Haemophilia. 2021 Jan;27(1):e88-e92. doi: 10.1111/hae.14206. Epub 2020 Nov 27.
Haemophilia A (HA) is an X-linked bleeding disorder caused by mutations in the coagulation factor Ⅷ (F8) gene. Its incidence in men is estimated to be approximately 1/5000.
This study aimed to characterize the mutation spectrum of the F8 gene in 485 Chinese families, encompassing all HA phenotypic classes. Additionally, we evaluated the accuracy of prenatal diagnosis of foetuses at risk of having HA.
Long-Distance PCR (LD-PCR) and Multiplex PCR were used to detect inversions, next-generation sequencing (NGS) was used for point mutations, and multiplex ligation-dependent probe amplification (MLPA) was used for large deletions or duplications.
A mutation spectrum of 478 HA families was produced. Throughout 26 exons and 15 introns, a total of 237 different alterations of mutations were detected, of which 146 are known mutations (64.5%) and 91 are novel mutations (35.5%). Prenatal diagnosis revealed 97 normal males (35.79%), 103 HA males (38.01%), 36 normal females (13.28%), and 38 HA carrier females (14.02%).
Using a systematic approach comprised of three steps, 237 pathogenic variants in 478 out of 485 patient samples (98.6%) were detected, including the identification of a heterogeneous mutation spectrum of 91 novel mutations. In addition, prenatal diagnosis of HA in pregnant carriers allowed for accurate determination of the foetal F8 gene state.
血友病 A(HA)是一种由凝血因子 Ⅷ(F8)基因突变引起的 X 连锁出血性疾病。据估计,男性发病率约为 1/5000。
本研究旨在描述 485 个中国 HA 家系的 F8 基因突变谱,涵盖所有 HA 表型类别。此外,我们评估了对有 HA 风险胎儿进行产前诊断的准确性。
长距离 PCR(LD-PCR)和多重 PCR 用于检测倒位,下一代测序(NGS)用于点突变,多重连接依赖性探针扩增(MLPA)用于大片段缺失或重复。
产生了 478 个 HA 家系的突变谱。在 26 个外显子和 15 个内含子中,共检测到 237 种不同的突变改变,其中 146 种是已知突变(64.5%),91 种是新突变(35.5%)。产前诊断发现 97 例正常男性(35.79%)、103 例 HA 男性(38.01%)、36 例正常女性(13.28%)和 38 例 HA 携带者女性(14.02%)。
通过采用包括三个步骤的系统方法,在 478 个患者样本中的 237 个致病变异体(98.6%)中进行了检测,包括确定 91 个新突变的异质突变谱。此外,对妊娠携带者中的 HA 进行产前诊断可准确确定胎儿 F8 基因状态。